Citation Impact
Citing Papers
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
2004 StandoutNobel
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
2003 StandoutScience
Interaction of Hydroxylated Collagen IV with the von Hippel-Lindau Tumor Suppressor
2007 StandoutNobel
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma
2005 StandoutNobel
Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
2008
pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
2007 StandoutNobel
Surgical management of brainstem hemangioblastomas in patients with von Hippel—Lindau disease
2003
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
The Clinical Presentation (Symptoms and Signs) of Sporadic and Familial Chromaffin Cell Tumours (Phaeochromocytomas and Paragangliomas)
2003
Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis
1990 Standout
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
2008 StandoutNobel
Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect
1995
Multiple Neuroendocrine Tumors of the Pancreas in von Hippel-Lindau Disease Patients
1998
Von hippel-lindau disease: New strategies in early detection and treatment
1994
Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes
2001
Histopathology and Molecular Genetics of Multiple Cysts and Microcystic (Serous) Adenomas of the Pancreas in von Hippel-Lindau Patients
2000
Recent Insights into the Molecular Pathogenesis of Pheochromocytoma and Paraganglioma
2006 StandoutNobel
Von Hippel‐Lindau gene alterations in sporadic benign and malignant pheochromocytomas
2003
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
2004 StandoutNobel
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Phaeochromocytoma
2005 Standout
Hypoxia and Inflammation
2011 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Hereditary paraganglioma targets diverse paraganglia: Table 1
2002
Utility of Plasma Free Metanephrines for Detecting Childhood Pheochromocytoma
2002
Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: Implications on epithelial stem cells
1989 Standout
Von Hippel‐Lindau disease
2003
Radiosurgery for hemangioblastoma: Results of a multiinstitutional experience
1996
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Oxygen sensing by HIF hydroxylases
2004 StandoutNobel
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
Celiac Disease
2007 Standout
Pheochromocytomas: Detection with18F DOPA Whole-Body PET—Initial Results
2002
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
2002 StandoutNobel
Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein
1999 StandoutNobel
T cell recognition as the target for immune intervention in autoimmune disease
1989
von Hippel-Lindau disease
2003 Standout
Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor
2004 StandoutNobel
Distinct sets of SEC genes govern transport vesicle formation and fusion early in the secretory pathway
1990 StandoutNobel
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
HIF hydroxylation and the mammalian oxygen-sensing pathway
2003 StandoutNobel
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
2006
Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo
2006 StandoutNobel
Modifiers of risk of hereditary breast and ovarian cancer
2002
Germline mutations in thevhl gene in patients presenting with phaeochromocytomas
1998
Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: Diagnostic and management recommendations
1998
Distinct Clinical Features of Paraganglioma Syndromes Associated With <EMPH TYPE="ITAL">SDHB</EMPH> and <EMPH TYPE="ITAL">SDHD</EMPH> Gene Mutations
2004
Pancreatic involvement in von Hippel–Lindau disease
2000
The natural history of hemangioblastomas of the central nervous system in patients with von Hippel—Lindau disease
2003
Mechanisms of angiogenesis
1997 StandoutNature
Sarcoidosis
1997 Standout
Primary Biliary Cirrhosis
1996
Plasma Normetanephrine and Metanephrine for Detecting Pheochromocytoma in von Hippel–Lindau Disease and Multiple Endocrine Neoplasia Type 2
1999
Pheochromocytoma: The Expanding Genetic Differential Diagnosis
2003
Pheochromocytoma: Update on Diagnosis, Localization, and Management
1995
Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease
2000
Surgical management of spinal cord hemangioblastomas in patients with von Hippel—Lindau disease
2003
Sporadic Pheochromocytomas Are Rarely Associated with Germline Mutations in thevhlTumor Suppressor Gene or theretProtooncogene1
1997
Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
2008 StandoutNobel
Celiac Sprue
1991
Differential Genetic Alterations in von Hippel-Lindau Syndrome-Associated and Sporadic Pheochromocytomas1
2000
Amyotrophic Lateral Sclerosis
2001 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
Pancreatic lesions in von Hippel–Lindau disease
2002
Hepatobiliary transport
2000
Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease
2000
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Identification of dipeptidyl peptidase IV as a protein shared by the plasma membrane of hepatocytes and liver biomatrix
1985 StandoutNobel
Structural Basis for Gluten Intolerance in Celiac Sprue
2002 StandoutScience
Diagnosis of Pheochromocytoma
1988
The Clinical and Pathological Manifestations of Renal Tumors in Von Hippel-Lindau Disease
1994
Binding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and C
1995 StandoutScienceNobel
Molecular Basis of Genetic Heterogeneity: Role of the Clinical Neurologist
1998
von Hippel-Lindau Disease
2006 StandoutNobel
Primary Biliary Cirrhosis
2011 Standout
PROLINE HYDROXYLATION AND GENE EXPRESSION
2005 StandoutNobel
Pathology, genetics and cell biology of hemangioblastomas.
1996
RENAL CANCER IN FAMILIES WITH HEREDITARY RENAL CANCER: PROSPECTIVE ANALYSIS OF A TUMOR SIZE THRESHOLD FOR RENAL PARENCHYMAL SPARING SURGERY
1999
Activation and differentiation requirements of primary T cells in vitro.
1993 StandoutNobel
Metabolic Glycoengineering with N‐Acyl Side Chain Modified Mannosamines
2016
Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
1994
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
Pheochromocytoma
2002
pVHL 19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation
1998 StandoutNobel
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
1999 StandoutScienceNobel
Pheochromocytoma: State-of-the-Art and Future Prospects
2003
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Tumor Recurrence and Hypertension Persistence After Successful Pheochromocytoma Operation
1997
Distinct biochemical requirements for the budding, targeting, and fusion of ER-derived transport vesicles.
1991 StandoutNobel
Genotype–phenotype correlations in von hippel–lindau disease
1998
Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer.
1989
Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
1995
Treatment of Intramedullary Hemangioblastomas, with Special Attention to von Hippel-Lindau Disease
2003
Haemangioblastoma of the central nervous system in von Hippel–Lindau disease
1998
Isolation of a vesicular intermediate in the cell-free transfer of membrane from transitional elements of the endoplasmic reticulum to Golgi apparatus cisternae of rat liver.
1988
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
The life history of cells in renewing systems
1981
Von Hippel-Lindau Syndrome
1999
Adrenal-sparing surgery for phaeochromocytoma
1999
Phaeochromocytoma with Normal Urinary Catecholamines: The Potential Value of Urinary Free Metadrenalines
2002
Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
1995
Duodenal Somatostatinoma and Erythrocytosis in a Patient with Von Hippel-Lindau Disease Type 2A.
2001
Consequences of Direct Genetic Testing for Germline Mutations in the Clinical Management of Families With Multiple Endocrine Neoplasia, Type II
1995
Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.
1990 Standout
LAPAROSCOPIC SURGERY FOR PHEOCHROMOCYTOMA: ADRENALECTOMY, PARTIAL RESECTION, EXCISION OF PARAGANGLIOMAS
1998
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
Surgical Management of Multi-Organ Visceral Tumors In Patients With Von Hippel-Lindau Disease: A Single Stage Approach
2003
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
CLINICAL AND GENETIC CHARACTERIZATION OF PHEOCHROMOCYTOMA IN VON HIPPEL-LINDAU FAMILIES: COMPARISON WITH SPORADIC PHEOCHROMOCYTOMA GIVES INSIGHT INTO NATURAL HISTORY OF PHEOCHROMOCYTOMA
1999
Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
1997
Pheochromocytomas and Paragangliomas in von Hippel–Lindau Disease
2002
Metabolisches Glykoengineering mit N‐Acyl‐Seiten‐ ketten‐modifizierten Mannosaminen
2016
The Molecular Basis of Von Hippel-Lindau Disease
1997 StandoutNobel
Works of B Volk being referenced
Association of primary biliary cirrhosis with the allele HLA-DPB1*0301 in a German population
1995
Pheochromocytomas, Multiple Endocrine Neoplasia Type 2, and von Hippel-Lindau Disease
1993
Exploring the genetic role of the HLA-DPB1 locus in Chileans with intrahepatic cholestasis of pregnancy
1996
Endolymphatic sac tumours
1998
Pancreatic lesions in the von Hippel-Lindau syndrome
1991
Congenital axonal neuropathy caused by deletions in the spinal muscular atrophy region
1997
Identification of the 110 000Mrglycoprotein isolated from rat liver plasma membrane as dipeptidylaminopeptidase IV
1982
Deafness due to bilateral endolymphatic sac tumours in a case of von Hippel-Lindau syndrome.
1996
Different half-lives of the carbohydrate and protein moieties of a 110,000-dalton glycoprotein isolated from plasma membranes of rat liver.
1980
Central nervous system lesions in von Hippel-Lindau syndrome.
1992
An extended HLA-D region haplotype associated with celiac disease.
1988